George Kassimis
Overview
Explore the profile of George Kassimis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
132
Citations
597
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kofos C, Papazoglou A, Rousopoulou S, Douki P, Takas A, Samaras A, et al.
Hellenic J Cardiol
. 2024 Oct;
PMID: 39414026
No abstract available.
12.
Stachteas P, Nasoufidou A, Karagiannidis E, Patoulias D, Karakasis P, Alexiou S, et al.
J Clin Med
. 2024 Sep;
13(18).
PMID: 39336895
Atrial fibrillation (AF) is the most prevalent arrhythmia among adults worldwide, frequently co-occurring with comorbidities such as Heart Failure (HF) and Type 2 Diabetes Mellitus (T2DM). This association contributes to...
13.
Mitsis A, Khattab E, Myrianthefs M, Tzikas S, Kadoglou N, Fragakis N, et al.
Biomedicines
. 2024 Sep;
12(9).
PMID: 39335646
Chemerin, an adipokine known for its role in adipogenesis and inflammation, has emerged as a significant biomarker in cardiovascular diseases, including acute myocardial infarction (AMI). Recent studies have highlighted chemerin's...
14.
Zormpas G, Boulmpou A, Potoupni V, Siskos F, Chatzipapa N, Fragakis N, et al.
Cardiol Rev
. 2024 Sep;
PMID: 39254543
In the context of the global burden of cardiovascular disease, the development of novel, patient-targeted diagnostic and therapeutic strategies is of paramount importance. Acute coronary syndromes (ACS) comprise a subset...
15.
Mitsis A, Myrianthefs M, Sokratous S, Karmioti G, Kyriakou M, Drakomathioulakis M, et al.
Biomedicines
. 2024 Aug;
12(8).
PMID: 39200135
Acute coronary syndrome (ACS) remains a major cause of morbidity and mortality worldwide, requiring ongoing efforts to identify novel therapeutic targets to improve patient outcomes. This manuscript reviews promising therapeutic...
16.
Theodoropoulos K, Didagelos M, Topaloglou K, Atrashkevich E, Kassimis G, Ziakas A
Coron Artery Dis
. 2024 Aug;
36(2):180-182.
PMID: 39189142
No abstract available.
17.
Karakasis P, Fragakis N, Patoulias D, Theofilis P, Kassimis G, Karamitsos T, et al.
Adv Ther
. 2024 Aug;
41(10):3749-3756.
PMID: 39141282
Introduction: Despite the technological advancements in catheter ablation strategies, the recurrence of atrial fibrillation (AF) post-ablation remains a concern that requires further investigation. Glucagon-like peptide 1 (GLP-1) receptor agonists have...
18.
Mitsis A, Eftychiou C, Kadoglou N, Theodoropoulos K, Karagiannidis E, Nasoufidou A, et al.
J Clin Med
. 2024 Jul;
13(14).
PMID: 39064126
Engaging intracoronary imaging (IC) techniques such as intravascular ultrasound or optical coherence tomography enables the precise description of vessel architecture. These imaging modalities have well-established roles in providing guidance and...
19.
Karakasis P, Patoulias D, Popovic D, Pamporis K, Theofilis P, Nasoufidou A, et al.
Curr Probl Cardiol
. 2024 Jul;
49(9):102742.
PMID: 39002620
Background Clinical and translational research suggests that mineralocorticoid receptor antagonists (MRAs) may prevent atrial fibrosis and electrical remodeling associated with atrial fibrillation (AF). This study aimed to consolidate existing evidence...
20.
Kassimis G, Samaras A, Nasoufidou A, Theodoropoulos K, Didagelos M, Rampidis G, et al.
Coron Artery Dis
. 2024 Jul;
35(8):705-706.
PMID: 38989960
No abstract available.